Disfunzioni sessuali post-SSRI

Screening and treatment of Post-Selective Serotonin Reuptake Inhibitors sexual dysfunctions Dépistage et traitement des dysfonctions sexuelles suivant un traitement par inhibiteur sélectif de la recapture de la sérotonine Author links open overlay panel V. Achour a b   M. Masson c   C. Lancon a b   L. Boyer a b   G. Fond a b a Hôpitaux universitaires de Marseille, department de psychiatrie universitaire, EA 3279: Aix-Marseille Université, CEReSS–Health Service Research and Quality of Life Center, 27, boulevard Jean-Moulin, 13005 Marseille, France b Nightingale Hospitals-Paris, clinique du Château de Garches, 11, bis rue de la Porte Jaune, 92380 Garches, France c Service Hospitalo-Universitaire, CH Sainte Anne, 1, rue Cabanis, 75014 Paris, France Available online 12 August 2022. https://www.sciencedirect.com/science/article/abs/pii/S0013700622001531?via%3Dihub

Post-Selective Serotonin Reuptake Inhibitor Sexual Dysfunctions (PSSD): Clinical Experience with a Multimodal Approach Yacov Reisman 1,*, Tommaso B. Jannini 2, Emmanuele A. Jannini 3   1 Department of Sexual Medicine, Flare-Health, 1183DJ Amstelveen, The Netherlands 2 School of Psychiatry, Department of Systems Medicine, University of Rome Tor Vergata, 00133 Rome, Italy 3 Chair of Endocrinology and Medical Sexology (ENDOSEX), Department of Systems Medicine, University of Rome Tor Vergata, 00133 Rome, Italy *Correspondence: reisman@flare-health.nl (Yacov Reisman) J. Mens. Health 2022 , 18(8), 165; https://doi.org/10.31083/j.jomh1808165 Submitted: 28 December 2021 | Revised: 24 February 2022 | Accepted: 18 March 2022 | Published: 1 August 2022 Copyright: © 2022 The Author(s). Published by IMR Press. This is an open access article under the CC BY 4.0 license. Abstract Background: Post-SSRI sexual dysfunction (PSSD) is a set of heterogeneous sexual disorders, that may arise during the adm